Vistakon
Industry
- Pharmaceuticals
- OTC, Consumer
- Medical Devices
Latest on Vistakon
The Together Rx Access patient assistance program sponsored by a group of large pharmaceutical manufacturers has announced it will close at the end of 2013 because those being helped through the progr
Valeant Pharmaceuticals International Inc. is poised to be a major player in the ophthalmic device and drug market with its agreement to pay $8.7 billion in debt and equity to acquire privately held
Generics powerhouse Allergan PLC may have said no, but Valeant Pharmaceuticals International Inc. CEO Michael Pearson always seems to have another vision, even if he needs to adjust his horizo
Generics powerhouse Allergan PLC may have said no, but Valeant Pharmaceuticals International Inc. CEO Michael Pearson always seems to have another vision, even if he needs to adjust his horizo